Characterization and treatment patterns of patients treated with immediate-release sodium oxybate for narcolepsy: A propensity score–matched cohort study
No significant differences in comorbidities were observed between cohorts. Although SXB is a highly effective treatment for narcolepsy, this study highlights challenges patients face while taking twice-nightly SXB, which may result in underuse/misuse and suboptimal treatment.
Authors
- Samir Awasthi (ORCID: https://orcid.org/0000-0001-8392-0205)
- Shahir Asfahan (ORCID: https://orcid.org/0000-0002-4709-2200)
- Lois E. Krahn
- Maja Tippmann‐Peikert
- Melissa C. Lipford (ORCID: https://orcid.org/0009-0001-1764-2822)
- Jennifer Gudeman (ORCID: https://orcid.org/0000-0002-7375-5020)
- Praveen Kumar (ORCID: https://orcid.org/0000-0002-9318-1167)
- Wui Ip (ORCID: https://orcid.org/0000-0002-9459-3702)
- Gajinder Pal Singh
- James L. Moore (ORCID: https://orcid.org/0000-0003-0254-8566)
Institutions
- Mayo Clinic in Arizona (US)
- Mayo Clinic Hospital (US)
- Nference (India) (IN)
- Baptist Health Louisville (US)
- Nference (United States) (US)
- Citadel (US)
Publication Details
- Journal
- Journal of Clinical Neuroscience
- Published
- 2025-03-22
- DOI
- https://doi.org/10.1016/j.jocn.2025.111185
- Citations
- 2
- Primary Topic
- Sleep and Wakefulness Research
- Type
- article
- Field-Weighted Citation Impact
- 2.86